{"transactions":[{"id":2600566,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":136226,"kind":"person","name":"INSLEY THOMAS","position":1,"cik":"0001239545","reported_name":"INSLEY THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series 1d Preferred Stock","published_at":"2021-08-17T16:40:45.000Z","date":"2021-08-17","kind":"exercise","acquired":false,"shares":30910,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Insley Family Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series 1d Preferred Stock converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the \"IPO\"). The Series 1d Preferred Stock was convertible at any time and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series 1d Preferred Stock converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the \"IPO\"). The Series 1d Preferred Stock was convertible at any time and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series 1d Preferred Stock converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the \"IPO\"). The Series 1d Preferred Stock was convertible at any time and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4581},"source":{"system":"sec-edgar","filing":"0000905718-21-001098","document":"dermata_fm4aug172021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853816/000090571821001098/dermata_fm4aug172021.xml","form_type":"4"}},{"id":2600565,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":136226,"kind":"person","name":"INSLEY THOMAS","position":1,"cik":"0001239545","reported_name":"INSLEY THOMAS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-17T16:40:45.000Z","date":"2021-08-17","kind":"exercise","acquired":true,"shares":4581,"ownership":{"direct":false,"nature":"By Insley Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series 1d Preferred Stock converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the \"IPO\"). The Series 1d Preferred Stock was convertible at any time and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":14337,"source":{"system":"sec-edgar","filing":"0000905718-21-001098","document":"dermata_fm4aug172021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853816/000090571821001098/dermata_fm4aug172021.xml","form_type":"4"}}]}